Clinical features and management of primary biliary cirrhosis

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 21

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jun 7, 2008; 14(21): 3313-3327
Published online Jun 7, 2008. doi: 10.3748/wjg.14.3313

Table 4 Pharmacological characteristics of the opiate antagonists investigated in clinical studies

	Pharmacological characteristics
Naloxone	Very short half life
	Intravenous continuous infusion
	Dose: 0.2-0.4 &mgr;g/kg per minute
Nalmefene	Longer half life
	Oral administration
	2 mg twice/d with a gradual increase until 20 mg twice/d
Naltrexone	Longer half life
	Oral administration
	50 mg/d
	(in two divided doses the first day and subsequently in a unique dose)

Citation: Crosignani A, Battezzati PM, Invernizzi P, Selmi C, Prina E, Podda M. Clinical features and management of primary biliary cirrhosis. World J Gastroenterol 2008; 14(21): 3313-3327
URL: https://www.wjgnet.com/1007-9327/full/v14/i21/3313.htm
DOI: https://dx.doi.org/10.3748/wjg.14.3313

Crosignani A, Battezzati PM, Invernizzi P, Selmi C, Prina E, Podda M. Clinical features and management of primary biliary cirrhosis. World J Gastroenterol 2008; 14(21): 3313-3327 [PMID: 18528929 DOI: 10.3748/wjg.14.3313]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.